Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam Injection for Postoperative Abdominal Pain
CTR20231709Phase 2Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of meloxicam in postoperative pain, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Jun 2023; status: completed.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20231709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231709.